Health

Wong To Yick Unveils Revitalised Official Website

Launching a New No.1 Brand Chapter with Ambassador Joey Yung Enhanced Authenticity Guidance & Usage Education for Elevated Consumer Confidence    [High-resolution promotional photo download: Here ] HONG KONG,...

2025-12-22 09:00 1594

Fosun International Honored with TVB's Highest Accolade, "Outstanding ESG Award"

HONG KONG, Dec. 22, 2025 /PRNewswire/ -- On 19 December 2025, the TVB ESG Awards 2025 Presentation Ceremony, hosted by Television Broadcasts Limited ("TVB"), was held at the Hong Kong Convention and Exhibition Center. Fosun International was honored with the highest accolade, the "Outstanding ESG...

2025-12-22 09:00 4496

Precision Medicine Portfolio Update: Illuccix China Phase 3 Study, TLX101-CDx and TLX250-CDx FDA Resubmissions

MELBOURNE, Australia and INDIANAPOLIS, Dec. 22, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today provides a precision medicine portfolio update in relation to: * TLX591-CDx (Illuccix® in approved jurisdictions, 68Ga-PSMA-11): Positive data from Phase ...

2025-12-22 05:40 2104

T-MAXIMUM Pharmaceutical's Allogeneic CAR-T Therapy MT027 Receives FDA IND Clearance to Proceed to Phase II clinical Trial for Recurrent Glioblastoma

BEIJING, Dec. 21, 2025 /PRNewswire/ -- T-MAXIMUM Pharmaceutical announced that its proprietary allogeneic, B7-H3-targeted CAR-T therapy, MT027, has received IND Clearance from the U.S. Food and Drug Administration (FDA) to initiate a Phase II clinical trial for the treatment of recurrent glioblas...

2025-12-21 20:20 2314

Jacobio Pharma Enters Global Exclusive License Agreement with AstraZeneca for Pan-KRAS Inhibitor JAB-23E73

BEIJING, SHANGHAI and BOSTON, Dec. 21, 2025 /PRNewswire/ -- Jacobio Pharma (1167.HK,) today announced that it has entered an agreement with AstraZeneca for its proprietary Pan-KRAS inhibitor JAB-23E73. AstraZeneca will receive exclusive development and commercialisation rights outside ofChina, wh...

2025-12-21 20:15 2364

Alphamab Oncology Announces Biparatopic HER2-targeting ADC JSKN003 Was Granted Breakthrough Therapy Designation by the FDA for the Treatment of PROC

SUZHOU, China, Dec. 20, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the biparatopic HER2-targeting antibody-drug conjugate (ADC) JSKN003, independently developed by the Company, and co-developed with JMT-Bio Technology Co., Ltd., a wholly-owned subsidiary of CSPC P...

2025-12-20 12:54 5098

Gene Solutions Concludes Successful ESMO Asia Congress 2025 with AI-Powered Multi-Omics Liquid Biopsy Symposium and Two Best Poster Awards

SINGAPORE, Dec. 20, 2025 /PRNewswire/ -- Gene Solutions, a pioneering genetic testing company, announced key achievements at the European Society for Medical Oncology (ESMO) Asia Congress 2025—held inSingapore on December 5–7. Highlights included a full-house symposium, seven scientific abstracts...

2025-12-20 11:14 5128

Tokyo Lifestyle Co., Ltd. Reports First Six Months of Fiscal Year 2026 Financial Results

Revenue Increased by 94.3% YoY; Gross Profit Increased by 29.8% YoY TOKYO, Dec. 19, 2025 /PRNewswire/ -- Tokyo Lifestyle Co., Ltd. ("Tokyo Lifestyle" or the "Company") (Nasdaq: TKLF), a retailer and wholesaler of Japanese beauty and health products, sundry products, luxury products, electronic p...

2025-12-20 05:05 7931

Ceretone Showcases Core One Pro -- The Nearly Invisible OTC Hearing Aid -- at CES 2026

Ceretone invites CES attendees to experience its latest penny-sized, feather-light hearing solution and complimentary hearing tests at Booth #54619 LAS VEGAS, Dec. 19, 2025 /PRNewswire/ -- Ceretone , a consumer health technology company dedicated to making quality hearin...

2025-12-20 02:00 2810

Woori IO Shareholders Approve Share Exchange to Become Wholly-Owned Subsidiary of OSR Holdings

Company advancing dual clinical pathways, including a Samsung-supported PoC trial in Korea and a planned U.S. FDA trial with a leadingCalifornia research university BELLEVUE, Wash., Dec. 19, 2025 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ: OSRH) ("OSR Holdings"), a global healthcare holding comp...

2025-12-20 00:50 7007

Pictor's Test Poised to Transform Hepatitis B Immunity Testing Amid CDC Guidance Shifts

CARLSBAD, Calif., Dec. 19, 2025 /PRNewswire/ -- With the CDC's Advisory Committee on Immunization Practices (ACIP) recommending post-vaccination antibody testing for hepatitis B, laboratories are facing new demands to assess immunity more effectively. Pictor

2025-12-19 22:17 2859

VARON Enhances Customer Access to Oxygen Concentrators Through Its Official Online Store

NEW YORK, Dec. 19, 2025 /PRNewswire/ -- As more individuals, families, and caregivers research oxygen therapy solutions online, knowingwhere to buy a reliable oxygen concentrator has become an important part of the decision-making process. With increasing demand for clear product information, au...

2025-12-19 19:52 2738

WuXi Biologics Achieves CDP Highest "A" Ratings in Both Climate Change and Water Security

SHANGHAI, Dec. 19, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK) announced that it has been named to the CDP "A" lists for both Climate Change and Water Security for 2025, underscoring its leadership in environmental stewardship and transparent disclosure. Climate Change Leadership Being recogn...

2025-12-19 17:30 3649

Prepare for a Healthier Holiday Season with Wellness Tips from VARON Oxygen Concentrators

MANILA, Philippines , Dec. 19, 2025 /PRNewswire/ -- As the holiday season begins to unfold inthe Philippines, families are starting to plan gatherings, reunions, and early celebrations. For households with elderly relatives or loved ones managing respiratory conditions such as COPD, asthma or oth...

2025-12-19 13:48 2805

FWD Insurance Berhad takes home ESG Plus Awards for empowering Malaysian communities

Programmes reaching thousands of students recognised for driving financial literacy and inclusion nationwide. KUALA LUMPUR, Malaysia, Dec. 19, 2025 /PRNewswire/ -- FWD Insurance Berhad ("FWD Insurance") has been recognised at the ESG Plus Awards 2025, organised by The Exchange Asia, receiving th...

2025-12-19 13:44 4013

SG-based Startup Galatek Raises $30M Series A to Accelerate AI-powered Automation in Life Sciences and Semiconductor Manufacturing

SINGAPORE, Dec. 19, 2025 /PRNewswire/ -- Galatek, a fast-growing Singapore -based automation and artificial intelligence (AI) startup, announced today that it has secured approximately US$30 million in Series A funding. The funding will accelerate the company's development of innovative products i...

2025-12-19 10:47 4410

NEW DRUG APPLICATION FOR TINENGOTINIB TABLETS ACCEPTED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION

NANJING, China and GAITHERSBURG, Md., Dec. 18, 2025 /PRNewswire/ -- TransThera Sciences Nanjing, Inc. (the "TransThera") announced that the new drug application for Tinengotinib tablets has been accepted by the Center for Drug Evaluation ("CDE")of the National Medical Products Administration ("NM...

2025-12-19 09:46 3533

NGT Launches Wellness Campaign with JOGUMAN…Unveils Four Special-Edition Products

SEOUL, South Korea, Dec. 19, 2025 /PRNewswire/ -- Natural Good Things (NGT), a women's inner-care brand, has partnered with JOGUMAN—an IP managed globally by IPX (formerlyLINE FRIENDS)—to launch its new wellness campaign, "Small but Healthy." Through the meeting, NGT has introduced four special-e...

2025-12-19 09:19 2723

MEDIPOST Announces the Exclusive Commercialization License Agreement with Teikoku Seiyaku for Knee Osteoarthritis Treatment CARTISTEM® in Japan

- South Korean biotech company secures US$8 million in upfront payment for the joint commercialization of the stem cell therapy CARTISTEM® targeting the Japanese knee osteoarthritis market. SEOUL, South Korea, Dec. 19, 2025 /PRNewswire/ -- MEDIPOST Co., Ltd. (KOSDAQ 078160), a fully integrated c...

2025-12-19 08:39 3262

Corti Unlocks "Surgical" AI Improvement, Outperforming Big Tech in Interpretability Benchmark

New "GIM" method tops MIB global leaderboard, offering the industry a scalable way to inspect and improve billion-parameter models. COPENHAGEN, Denmark and NEW YORK, Dec. 19, 2025 /PRNewswire/ -- Corti

2025-12-19 05:12 2819
12345678 ... 871